Company profile
Herantis Pharma Plc.
Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s.
- Industry
- Biotechnology Research
- Employees
- 24
- Headquarters
- Espoo, Southern Finland
- Founded
- 2008
- LinkedIn followers
- 6,066
- Office locations
- 1
Herantis Pharma Plc. company summary
Herantis Pharma Plc. is a company in the Biotechnology Research industry, headquartered in Espoo, Southern Finland, founded in 2008. On LinkedIn the company has around 24 employees and 6,066 followers. Its listed specialties include Parkinson's disease, Neurodegenerative diseases, Biologics, biotech, drug development.
What technology does Herantis Pharma Plc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Herantis Pharma Plc.
Herantis Pharma Plc is a clinical-stage biotechnology company developing disease-modifying therapies for Parkinson’s disease. The Company’s lead product, HER-096, is a first-in-class small peptide that combines the neuroprotective mechanism of cerebral dopamine neurotrophic factor (CDNF), with the convenience of subcutaneous administration. In a Phase 1b clinical trial, HER 096 was shown to be generally safe and well tolerated in Parkinson’s disease patients. Herantis plans to advance HER-096 into a Phase 2 clinical trial in 2026 to evaluate efficacy, safety and tolerability in early-stage Parkinson’s patients. Herantis is listed on the Nasdaq First North Growth Market Finland.
Specialties
Where is Herantis Pharma Plc. located?
Herantis Pharma Plc. lists 1 location.
Compare companies similar to Herantis Pharma Plc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Herantis Pharma Plc. herantis.com | Biotechnology Research | 24 | 2008 | Espoo, Southern Finland |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Herantis Pharma Plc.
What does Herantis Pharma Plc. do?
Herantis Pharma Plc is a clinical-stage biotechnology company developing disease-modifying therapies for Parkinson’s disease. The Company’s lead product, HER-096, is a first-in-class small peptide that combines the neuroprotective mechanism of cerebral dopamine neurotrophic factor (CDNF), with the convenience of subcutaneous administration. In a Phase 1b clinical trial, HER 096 was shown to be generally safe and well tolerated in Parkinson’s disease patients. Herantis plans to advance HER-096 into a Phase 2 clinical trial in 2026 to evaluate efficacy, safety and tolerability in early-stage Parkinson’s patients. Herantis is listed on the Nasdaq First North Growth Market Finland.
How many employees does Herantis Pharma Plc. have?
Herantis Pharma Plc. has around 24 employees on LinkedIn.
Where is Herantis Pharma Plc. headquartered?
Herantis Pharma Plc. is headquartered in Espoo, Southern Finland.
When was Herantis Pharma Plc. founded?
Herantis Pharma Plc. was founded in 2008.
Build a lead list from companies like Herantis Pharma Plc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.